Literature DB >> 14760789

Patient questionnaires and formal education level as prospective predictors of mortality over 10 years in 97% of 1416 patients with rheumatoid arthritis from 15 United States private practices.

Theodore Pincus1, Julie Keysor, Tuulikki Sokka, Eswar Krishnan, Leigh F Callahan.   

Abstract

OBJECTIVE: To prospectively analyze patient questionnaire scores concerning functional disability as well as formal education level as potential predictors of premature mortality over 10 years in 1416 patients with rheumatoid arthritis (RA) from 15 private practice rheumatology settings in 11 diverse cities in the United States.
METHODS: At baseline in 1985 and periodically over 10 years, patients completed mailed self-report multidimensional health assessment questionnaires (MDHAQ) that included functional disability scores, formal education level, and other demographic and clinical data. Vital status was determined 10 years after baseline. Potential predictors of 10 year mortality were analyzed using descriptive statistics and Cox proportional hazards models.
RESULTS: Vital status was accounted for in 1378 patients, 97.3% of the cohort. The standard mortality ratio was 1.6, similar to most reported series of patients with RA, as 401 patients died versus 251 expected over 10 years. Evidence of "dose-response" relations was seen for age, formal education level, functional disability scores, and helplessness scores as predictors of mortality. In Cox proportional hazards models, age, sex, formal education level, functional disability, and helplessness scores remained significant independent predictors of 10 year mortality.
CONCLUSION: Functional disability and low formal education level are significant predictors of premature mortality in people with RA under care in US private practice settings, as in most reported cohorts of patients with RA. This study shows that it is possible to account for more than 95% of patients over 10 years using mailed questionnaires to monitor patient status.

Entities:  

Mesh:

Year:  2004        PMID: 14760789

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  19 in total

Review 1.  Pain, catastrophizing, and depression in the rheumatic diseases.

Authors:  Robert R Edwards; Christine Cahalan; Christine Calahan; George Mensing; Michael Smith; Jennifer A Haythornthwaite
Journal:  Nat Rev Rheumatol       Date:  2011-02-01       Impact factor: 20.543

2.  Patients' perceptions of health-related quality of life in rheumatoid arthritis.

Authors:  Montserrat Núñez; Esther Núñez; Alex Sanchez; José Luis del Val; María Bonet; Daniel Roig; Dolors Muñoz
Journal:  Clin Rheumatol       Date:  2009-06-27       Impact factor: 2.980

3.  Fibromyalgia and the Prediction of Two-Year Changes in Functional Status in Rheumatoid Arthritis Patients.

Authors:  Hyein Kim; Jing Cui; Michelle Frits; Christine Iannaccone; Jonathan Coblyn; Nancy A Shadick; Michael E Weinblatt; Yvonne C Lee
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-11-14       Impact factor: 4.794

4.  Moderators of the negative effects of catastrophizing in arthritis.

Authors:  Robert R Edwards; Jon Giles; Clifton O Bingham; Claudia Campbell; Jennifer A Haythornthwaite; Joan Bathon
Journal:  Pain Med       Date:  2010-03-04       Impact factor: 3.750

5.  Combined influence of genetic and environmental factors in age of rheumatoid arthritis onset.

Authors:  Luis Rodríguez-Rodríguez; José Ramón Lamas; Jezabel Varadé; Pilar Tornero-Esteban; Lydia Abasolo; Emilio Gomez de la Concha; Juan Angel Jover; Elena Urcelay; Benjamín Fernández-Gutiérrez
Journal:  Rheumatol Int       Date:  2011-09-16       Impact factor: 2.631

6.  Cardiovascular events are not associated with MTHFR polymorphisms, but are associated with methotrexate use and traditional risk factors in US veterans with rheumatoid arthritis.

Authors:  Lisa A Davis; Grant W Cannon; Lauren F Pointer; Leah M Haverhals; Roger K Wolff; Ted R Mikuls; Andreas M Reimold; Gail S Kerr; J Steuart Richards; Dannette S Johnson; Robert Valuck; Allan Prochazka; Liron Caplan
Journal:  J Rheumatol       Date:  2013-04-01       Impact factor: 4.666

7.  Predictors of bone density testing in patients with rheumatoid arthritis.

Authors:  J Aizer; G Reed; A Onofrei; M J Harrison
Journal:  Rheumatol Int       Date:  2008-12-21       Impact factor: 2.631

Review 8.  Challenges comparing functional limitations in rheumatoid arthritis and ankylosing spondylitis.

Authors:  G H Louie; J D Reveille; M M Ward
Journal:  Clin Exp Rheumatol       Date:  2009 Jul-Aug       Impact factor: 4.473

9.  Patient preferences and satisfaction in the treatment of rheumatoid arthritis with biologic therapy.

Authors:  Jennifer L Barton
Journal:  Patient Prefer Adherence       Date:  2009-11-29       Impact factor: 2.711

10.  Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database.

Authors:  T Sokka; H Kautiainen; T Pincus; S Toloza; G da Rocha Castelar Pinheiro; J Lazovskis; M L Hetland; T Peets; K Immonen; J F Maillefert; A A Drosos; R Alten; C Pohl; B Rojkovich; B Bresnihan; P Minnock; M Cazzato; S Bombardieri; S Rexhepi; M Rexhepi; D Andersone; S Stropuviene; M Huisman; S Sierakowski; D Karateev; V Skakic; A Naranjo; E Baecklund; D Henrohn; F Gogus; H Badsha; A Mofti; P Taylor; C McClinton; Y Yazici
Journal:  Ann Rheum Dis       Date:  2009-07-30       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.